Cheryl Arrowsmith
Cheryl H. Arrowsmith is a Canadian structural biologist and is the Chief Scientist at the Toronto laboratory of the Structural Genomics Consortium. Her contributions to protein structural biology includes the use of NMR and X-ray crystallography to pursue structures of proteins on a proteome wide scale.
She received her Ph.D. in chemistry at the University of Toronto in 1987 and post-doctoral training at Stanford University working with Oleg Jardetzky. One of her areas of interest is the tumour suppressor p53 and related proteins.
Her current research is to determine the 3-dimensional structures of human proteins of therapeutic relevance by structural proteomics. She made significant contributions to epigenetic signaling with her highest cited paper is "Epigenetic protein families: a new frontier for drug discovery" cited at 802 times, according to Google Scholar.
Arrowsmith was named a Fellow of the American Association for the Advancement of Science in 2015.
